Cyclopharm Seeks ASX Quotation for 192,097 New Shares

Cyclopharm Limited ( (AU:CYC) ) has provided an update.

Cyclopharm Limited has applied to the ASX for quotation of 192,097 new ordinary fully paid shares, with an issue date of 12 March 2026. The additional securities, issued under a previously announced transaction, will modestly expand the company’s listed share capital, providing incremental liquidity for investors without materially altering its market position.

The new share quotation reflects the routine progression of capital management activities that follow prior corporate disclosures. While the amount is relatively small, the issuance underscores Cyclopharm’s ongoing engagement with equity markets to support its strategic and operational objectives, and may slightly broaden the company’s shareholder base.

The most recent analyst rating on (AU:CYC) stock is a Hold with a A$0.69 price target. To see the full list of analyst forecasts on Cyclopharm Limited stock, see the AU:CYC Stock Forecast page.

More about Cyclopharm Limited

Cyclopharm Limited is an Australian-listed company on the ASX under the code CYC. The firm operates within the healthcare and life sciences sector, with its business centred on the development and commercialisation of medical products and technologies, although this particular filing provides only limited operational detail.

Average Trading Volume: 89,869

Technical Sentiment Signal: Sell

Current Market Cap: A$88.05M

Find detailed analytics on CYC stock on TipRanks’ Stock Analysis page.